These data suggested that TS-141 can potentially improve ADHD, and higher dose effects of TS-141 are expected for CYP2D6 EMs with ADHD patients, accounting for 80% of the Japanese population. This evidence concerns the gene CYP2D6 and attention deficit-hyperactivity disorder.